Trial – Fampridine-SR (can it improve walking ability and muscle strength in MS?)

Trial Information

Summary: A 21 WEEK STUDY TO EVALUATE SAFETY AND EFFICACY OF ORAL FAMPRIDINE-SR IN SUBJECTS WITH MULTIPLE SCLEROSIS.

The purpose of the study is to evaluate the safety and effectiveness of a new experimental drug, Fampridine-SR. Fampridine is being studied to see if it can improve walking ability and muscle strength in persons with MS.

Compensation Provided

Patient Inclusion

­          Male or female with clinically definite MS

­          Subject must be 18 to 70 years of age

Exclusion Criteria

­          Female who is either pregnant or breastfeeding

­          History of any seizure activities

­          Allergic to pyridine-containing substances

­          Previously treated with 4-AP

­          Medical condition (including psychiatric disease) that would interfere with the interpretation of the study results or the conduct of the study

If you would like to be part of this trial and don’t live in New York email this person.  Ask if trials for FAMPRIDINE-SR are being performed in other areas.